Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
With scientists predicting a sharp increase in COVID-19 infections, on 22nd September 2020 the UK Government announced a new round of measures to “confront the COVID-19 virus”
Prof Dr Daniela A. Wilson from the Institute for Molecules and Materials (IMM) tells us what we need to know about molecular intelligence – the rise of supramolecular nanomachines with controlled shape and motility.
Nishat spoke to Ed O’Donovan, Head of Protection at Front Line Defenders, to dissect pandemic obstacles faced by human rights defenders - especially Indigenous communities in Brazil.
Craig Hartley, UK Business Development Manager for OPEX Business Machines GmbH explains how their solutions are helping both the NHS and the wider Public Sector achieve digital transformation.
A new study shows travelling from the home is associated with significantly higher likelihood of contracting COVID-19, while strict social distancing prevents infection.
Emmanouil Avgerinos, Ioannis Fragkos and Yufei Huang explain that for surgical teams, shared experiences and hierarchical structures matter more than you think.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
